These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32628270)

  • 1. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 4. Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
    Rizzoli L; Collini L; Magnano M; Termine S; Barcelli R; Infusino SD; Bauer P; Rech G; Girardelli CR; Balestri R
    Br J Dermatol; 2020 Oct; 183(4):782-784. PubMed ID: 32613620
    [No Abstract]   [Full Text] [Related]  

  • 5. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
    Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
    J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay.
    Hébert V; Duval-Modeste AB; Joly P; Lemée V; Cellier L; Jouen F; Veber B; Drouot L; Boyer O
    J Am Acad Dermatol; 2020 Nov; 83(5):1434-1436. PubMed ID: 32682889
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
    Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
    JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
    Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
    J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
    [No Abstract]   [Full Text] [Related]  

  • 9. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M
    Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 11. Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Guglielmo A; Patrizi A; Neri I
    J Am Acad Dermatol; 2020 Dec; 83(6):1749-1751. PubMed ID: 33010953
    [No Abstract]   [Full Text] [Related]  

  • 12. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak.
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Jul; 83(1):e61-e63. PubMed ID: 32339703
    [No Abstract]   [Full Text] [Related]  

  • 14. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
    Kerber AA; Soma DB; Youssef MJ
    Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
    [No Abstract]   [Full Text] [Related]  

  • 15. Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France.
    Mattern J; Vauloup-Fellous C; Zakaria H; Benachi A; Carrara J; Letourneau A; Bourgeois-Nicolaos N; De Luca D; Doucet-Populaire F; Vivanti AJ
    PLoS One; 2020; 15(10):e0240782. PubMed ID: 33057392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Santonja C; Heras F; Núñez L; Requena L
    Br J Dermatol; 2020 Oct; 183(4):778-780. PubMed ID: 32585767
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
    Gómez-Fernández C; López-Sundh AE; González-Vela C; Ocejo-Vinyals JG; Mayor-Ibarguren A; Salas-Venero CA; Gutiérrez-Larrañaga M; Tejerina-Puente A; Fariñas MC; Cabero-Pérez MJ; López-Hoyos M; González-López MA
    Int J Dermatol; 2020 Dec; 59(12):1475-1484. PubMed ID: 33070314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.